B
Biogena
Focusing on products and services that help everyone around the world to achieve better health and well-being and the best possible development of their potential
At a glance
- Founded
- 2006
- Headquarters
- Salzburg, Austria
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- INInvesdor
Series B and later1 investor entered at this stage
- TCTauros Capital
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Investments and acquisitions
Disclosed deals where Biogena was the backer or acquirer, 2021–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Biogena's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Biogena's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biogena on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biogena on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.